XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Dow Consolidated Statements of Income Statement - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net sales $ 14,115 $ 14,837 $ 45,043 $ 40,604
Cost of sales 12,381 11,611 37,682 32,413
Research and development expenses 191 210 626 632
Selling, general and administrative expenses 356 403 1,289 1,209
Amortization of intangibles 83 100 256 301
Restructuring and asset related charges - net 0 0 186 22
Equity in earnings (losses) of nonconsolidated affiliates (58) 249 311 751
Sundry income (expense) - net 69 (350) 292 (225)
Interest income 41 14 105 35
Interest expense and amortization of debt discount 155 178 487 561
Income before income taxes 1,001 2,248 5,225 6,027
Provision for income taxes 241 542 1,232 1,383
Net income 760 1,706 3,993 4,644
Net income attributable to noncontrolling interests 21 23 24 69
Net income available for The Dow Chemical Company common stockholder $ 739 $ 1,683 $ 3,969 $ 4,575
Earnings per common share - basic $ 1.03 $ 2.25 $ 5.45 $ 6.11
Earnings per common share - diluted $ 1.02 $ 2.23 $ 5.41 $ 6.06
Weighted-average common shares outstanding - basic 714.3 744.5 724.9 745.4
Weighted-average common shares outstanding - diluted 718.1 750.0 729.8 750.9